As of 2025-09-17, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is (75.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 126.54 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is -160.0%.
The range of the Relative Valuation is (237.06) - 166.05 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.5x - 50.8x | 44.0x |
| Forward P/E multiples | 23.8x - 33.9x | 28.9x |
| Fair Price | (237.06) - 166.05 | (75.92) |
| Upside | -287.3% - 31.2% | -160.0% |
| Date | P/E |
| 2025-09-16 | -18.96 |
| 2025-09-15 | -18.76 |
| 2025-09-12 | -18.90 |
| 2025-09-11 | -19.25 |
| 2025-09-10 | -19.01 |
| 2025-09-09 | -19.26 |
| 2025-09-08 | -19.46 |
| 2025-09-05 | -19.40 |
| 2025-09-04 | -19.18 |
| 2025-09-03 | -19.74 |
| 2025-09-02 | -19.43 |
| 2025-08-29 | -19.14 |
| 2025-08-28 | -18.90 |
| 2025-08-27 | -18.64 |
| 2025-08-26 | -18.73 |
| 2025-08-25 | -18.67 |
| 2025-08-22 | -18.45 |
| 2025-08-21 | -18.06 |
| 2025-08-20 | -17.84 |
| 2025-08-19 | -17.86 |
| 2025-08-18 | -17.63 |
| 2025-08-15 | -17.65 |
| 2025-08-14 | -17.48 |
| 2025-08-13 | -17.55 |
| 2025-08-12 | -16.98 |
| 2025-08-11 | -16.59 |
| 2025-08-08 | -16.68 |
| 2025-08-07 | -16.79 |
| 2025-08-06 | -15.87 |
| 2025-08-05 | -16.96 |
| 2025-08-04 | -17.40 |
| 2025-08-01 | -17.31 |
| 2025-07-31 | -17.18 |
| 2025-07-30 | -17.40 |
| 2025-07-29 | -17.47 |
| 2025-07-28 | -17.59 |
| 2025-07-25 | -17.72 |
| 2025-07-24 | -17.68 |
| 2025-07-23 | -17.58 |
| 2025-07-22 | -17.43 |
| 2025-07-21 | -16.88 |
| 2025-07-18 | -16.91 |
| 2025-07-17 | -17.21 |
| 2025-07-16 | -17.39 |
| 2025-07-15 | -16.83 |
| 2025-07-14 | -16.70 |
| 2025-07-11 | -16.52 |
| 2025-07-10 | -16.85 |
| 2025-07-09 | -16.72 |
| 2025-07-08 | -16.35 |